* Corresponding authors

^a Pharmaceutical Sciences and Pharmacogenomics Graduate Program, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, USA
E-mail: Frank.szoka@ucsf.edu

^b Tricida Inc, South, San Francisco, California, USA

^c ZoneOne Pharma Inc., San Francisco, California, USA

^d Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, USA